PDF herunterladen
Semin intervent Radiol 2023; 40(02): 156-160
DOI: 10.1055/s-0043-57262
Review Article

Surgical, Endovascular, and Multimodal Approaches to the Management of Atherosclerotic Common Femoral Artery Disease

Nathan W. Kugler
1   Division of Vascular and Endovascular Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Common femoral artery disease is at the heart of nearly all treatment algorithms and decisions for patients with symptomatic peripheral arterial disease. Surgical endarterectomy has been the mainstay of common femoral treatment with a wealth of data supporting its safety, efficacy, and durability. Advances in endovascular technology and techniques for the management of iliac and superficial femoral artery disease has resulted in a paradigm shift in management. The common femoral artery has been aptly named a “no stent zone” due to anatomic and disease-specific challenges that have limited the role for endovascular techniques. New technology and techniques in the endovascular management of common femoral disease seek to change our treatment strategies. A multimodal approach utilizing a combination of angioplasty, atherectomy, and stenting has been shown most beneficial, although limited long-term data leave durability an unanswered question. While surgical treatment remains the gold standard, advances in the endovascular approach will certainly continue to improve outcomes. As truly isolated common femoral disease is a rarity, a collaborative approach combining all benefits of open and endovascular techniques in the treatment of peripheral arterial disease is essential.

Keywords

common femoral endarterectomy - common femoral angioplasty - endovascular - peripheral arterial disease - surgery - interventional radiology

DISCLOSURES

The authors have no potential conflicts of interest to disclose.




Publikationsverlauf

Artikel online veröffentlicht:
16. Juni 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Dos Santos JC. [On the depopulation of old arterial thromboses]. Mem Acad Chir (Paris) 1947; 73 (18-19): 409-411
    PubMedGoogle Scholar
  • 2 Elsherif M, Tawfick W, Elsharkawi M, Campell R, Hynes N, Sultan S. Common femoral artery endarterectomy in the age of endovascular therapy. Vascular 2018; 26 (06) 581-590
    CrossrefPubMedGoogle Scholar
  • 3 Malgor RD, Ricotta II JJ, Bower TC. et al. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization. Ann Vasc Surg 2012; 26 (07) 946-956
    CrossrefPubMedGoogle Scholar
  • 4 Siracuse JJ, Gill HL, Schneider DB. et al. Assessing the perioperative safety of common femoral endarterectomy in the endovascular era. Vasc Endovascular Surg 2014; 48 (01) 27-33
    CrossrefPubMedGoogle Scholar
  • 5 Kechagias A, Ylönen K, Biancari F. Long-term outcome after isolated endarterectomy of the femoral bifurcation. World J Surg 2008; 32 (01) 51-54
    CrossrefPubMedGoogle Scholar
  • 6 Uhl C, Götzke H, Zeman F. et al. Long-term outcome of common femoral artery endarterectomy in octogenarians and non-octogenarians. Scand J Surg 2021; 110 (03) 400-406
    CrossrefPubMedGoogle Scholar
  • 7 Kuyumdzhiev S, Kuyumdzhieva G, Tiwari A. Comparison of transverse versus longitudinal skin incisions for femoral endarterectomy and patchplasty. Vascular 2022; 30 (06) 1168-1173
    CrossrefPubMedGoogle Scholar
  • 8 Nakama T, Takahara M, Iwata Y. et al; CAULIFLOWER Study Investigators. 1-Year outcomes of thromboendarterectomy vs endovascular therapy for common femoral artery lesions: CAULIFLOWER study results. JACC Cardiovasc Interv 2022; 15 (14) 1453-1463
    CrossrefPubMedGoogle Scholar
  • 9 Nagatomi S, Ichihashi S, Yamamoto H. et al. Efficacy of multichannel balloon angioplasty in calcified common femoral artery lesions. J Vasc Interv Radiol 2021; 32 (02) 181-186
    CrossrefPubMedGoogle Scholar
  • 10 Imran HM, Hyder ON, Soukas PA. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Cardiovasc Revasc Med 2019; 20 (03) 210-214
    CrossrefPubMedGoogle Scholar
  • 11 Kuo TT, Chen PL, Huang CY, Lee CY, Shih CC, Chen IM. Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease. J Vasc Surg 2019; 69 (01) 141-147
    CrossrefPubMedGoogle Scholar
  • 12 Cotroneo AR, Iezzi R. The role of “cutting” balloon angioplasty for the treatment of short femoral bifurcation steno-obstructive disease. Cardiovasc Intervent Radiol 2010; 33 (05) 921-928
    CrossrefPubMedGoogle Scholar
  • 13 Baig M, Kwok M, Aldairi A. et al. Endovascular intravascular lithotripsy in the treatment of calcific common femoral artery disease: a case series with an 18-month follow-up. Cardiovasc Revasc Med 2022; 43: 80-84
    CrossrefPubMedGoogle Scholar
  • 14 Brodmann M, Schwindt A, Argyriou A, Gammon R. Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses. J Endovasc Ther 2019; 26 (03) 283-287
    CrossrefPubMedGoogle Scholar
  • 15 Tepe G, Brodmann M, Bachinsky W. et al. Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized disrupt PAD III trial. Journal of the Society for Cardiovascular Angiography & Interventions. 2022; 1 (04) 100341
    CrossrefPubMedGoogle Scholar
  • 16 Tepe G, Brodmann M, Werner M. et al; Disrupt PAD III Investigators. Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the Randomized Disrupt PAD III Trial. JACC Cardiovasc Interv 2021; 14 (12) 1352-1361
    CrossrefPubMedGoogle Scholar
  • 17 Mathisen SR, Akesson M, Lindh M, Ivancev K, Resch TA. Kissing stents in the common femoral artery bifurcation for critical limb ischemia: technical description and report of three cases. Vascular 2007; 15 (04) 211-214
    CrossrefPubMedGoogle Scholar
  • 18 Bath J, Avgerinos E. A pooled analysis of common femoral and profunda femoris endovascular interventions. Vascular 2016; 24 (04) 404-413
    CrossrefPubMedGoogle Scholar
  • 19 Thiney PO, Millon A, Boudjelit T, Della Schiava N, Feugier P, Lermusiaux P. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg 2015; 29 (05) 960-967
    CrossrefPubMedGoogle Scholar
  • 20 Bonvini RF, Rastan A, Sixt S. et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol 2011; 58 (08) 792-798
    CrossrefPubMedGoogle Scholar
  • 21 Wong G, Lahsaei S, Aoun J, Garcia LA. Management of common femoral artery occlusive disease: a review of endovascular treatment strategies and outcomes. Catheter Cardiovasc Interv 2019; 93 (03) 514-521
    CrossrefPubMedGoogle Scholar
  • 22 Martin R, Vanesa G DC, Raleigh JV. et al. Common femoral artery stenting: computed tomography angiography based long-term patency. Vasc Endovascular Surg 2021; 55 (06) 571-576
    CrossrefPubMedGoogle Scholar
  • 23 Linni K, Ugurluoglu A, Hitzl W, Aspalter M, Hölzenbein T. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial. J Endovasc Ther 2014; 21 (04) 493-502
    CrossrefPubMedGoogle Scholar
  • 24 Stricker H, Spinedi L, Limoni C, Giovannacci L. Stent-assisted angioplasty (SAA) at the level of the common femoral artery bifurcation: long-term outcomes. Cardiovasc Intervent Radiol 2020; 43 (04) 541-546
    CrossrefPubMedGoogle Scholar
  • 25 Picazo F, Kwok RCH, Hockley JA, Garbowski MW, Samuelson SD, Jansen SJ. Directional atherectomy of the common femoral artery: complications and outcomes. Ann Vasc Surg 2020; 66: 621-630
    CrossrefPubMedGoogle Scholar
  • 26 Böhme T, Romano L, Macharzina RR. et al. Outcomes of directional atherectomy for common femoral artery disease. EuroIntervention 2021; 17 (03) 260-266
    CrossrefPubMedGoogle Scholar
  • 27 Cioppa A, Franzese M, Gerardi D. et al. Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions. Catheter Cardiovasc Interv 2022; 99 (04) 1310-1316
    CrossrefPubMedGoogle Scholar
  • 28 Cioppa A, Stabile E, Salemme L. et al. Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes. EuroIntervention 2017; 12 (14) 1789-1794
    CrossrefPubMedGoogle Scholar
  • 29 Kronlage M, Erbel C, Lichtenberg M. et al. Safety and effectiveness of Phoenix atherectomy for endovascular treatment in calcified common femoral artery lesions. Vasa 2021; 50 (05) 378-386
    CrossrefPubMedGoogle Scholar
  • 30 Siracuse JJ, Van Orden K, Kalish JA. et al; Vascular Quality Initiative. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg 2017; 65 (04) 1039-1046
    CrossrefPubMedGoogle Scholar